Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
8.33
+0.19 (2.33%)
Nov 21, 2024, 3:13 PM EST - Market open
Iovance Biotherapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$23.33
Upside
+180.07%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +284.15% | Nov 6, 2024 |
| UBS | UBS | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +104.08% | Oct 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +284.15% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $19 → $10 | Buy → Hold | Downgrades | $19 → $10 | +20.05% | Jul 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +284.15% | Jun 28, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $25 → $23 | Buy | Maintains | $25 → $23 | +176.11% | Jun 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +284.15% | Jun 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +284.15% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +284.15% | May 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +284.15% | May 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $18 → $19 | Buy | Maintains | $18 → $19 | +128.09% | Mar 14, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $17 → $26 | Strong Buy | Maintains | $17 → $26 | +212.12% | Mar 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +284.15% | Mar 4, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $22 → $25 | Buy | Maintains | $22 → $25 | +200.12% | Mar 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +284.15% | Feb 29, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $19 → $21 | Strong Buy | Maintains | $19 → $21 | +152.10% | Feb 29, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.